These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 35696852)
41. Dendritic cell are able to differentially recognize Sporothrix schenckii antigens and promote Th1/Th17 response in vitro. Verdan FF; Faleiros JC; Ferreira LS; Monnazzi LG; Maia DC; Tansine A; Placeres MC; Carlos IZ; Santos-Junior RR Immunobiology; 2012 Aug; 217(8):788-94. PubMed ID: 22656886 [TBL] [Abstract][Full Text] [Related]
42. Susceptibility of species within the Sporothrix schenckii complex to a panel of killer yeasts. Stopiglia CD; Heidrich D; Sorrentino JM; Vieira FJ; Landell MF; Valente P; Scroferneker ML J Basic Microbiol; 2014 Jun; 54(6):578-84. PubMed ID: 23686831 [TBL] [Abstract][Full Text] [Related]
43. Asexual propagation of a virulent clone complex in a human and feline outbreak of sporotrichosis. Teixeira Mde M; Rodrigues AM; Tsui CK; de Almeida LG; Van Diepeningen AD; van den Ende BG; Fernandes GF; Kano R; Hamelin RC; Lopes-Bezerra LM; Vasconcelos AT; de Hoog S; de Camargo ZP; Felipe MS Eukaryot Cell; 2015 Feb; 14(2):158-69. PubMed ID: 25480940 [TBL] [Abstract][Full Text] [Related]
44. Canine sporotrichosis: polyphasic taxonomy and antifungal susceptibility profiles of Sporothrix species in an endemic area in Brazil. Boechat JS; Pereira SA; de Sá Machado AC; Viana PG; Almeida-Paes R; Zancopé-Oliveira RM; Gremião IDF; de Oliveira MME Braz J Microbiol; 2021 Mar; 52(1):135-143. PubMed ID: 32617836 [TBL] [Abstract][Full Text] [Related]
45. In vitro susceptibility of antifungal drugs against Sporothrix brasiliensis recovered from cats with sporotrichosis in Brazil. Brilhante RS; Rodrigues AM; Sidrim JJ; Rocha MF; Pereira SA; Gremião ID; Schubach TM; de Camargo ZP Med Mycol; 2016 Mar; 54(3):275-9. PubMed ID: 26591009 [TBL] [Abstract][Full Text] [Related]
46. Comparative proteomics in the three major human pathogenic species of the genus Sporothrix. Silva-Bailão MG; Lima PS; Oliveira MME; Oliveira LC; Almeida-Paes R; Borges CL; Bailão AM; Coelho ASG; Soares CMA; Zancopé-Oliveira RM Microbes Infect; 2021; 23(1):104762. PubMed ID: 32992009 [TBL] [Abstract][Full Text] [Related]
47. Milteforan, a promising veterinary commercial product against feline sporotrichosis. Carnero LCG; Dos Reis TF; Diehl C; de Castro PA; Pontes L; Pinzan CF; Goldman GH bioRxiv; 2024 Feb; ():. PubMed ID: 38405873 [TBL] [Abstract][Full Text] [Related]
48. Therapeutic vaccine using a monoclonal antibody against a 70-kDa glycoprotein in mice infected with highly virulent Sporothrix schenckii and Sporothrix brasiliensis. de Almeida JR; Kaihami GH; Jannuzzi GP; de Almeida SR Med Mycol; 2015 Jan; 53(1):42-50. PubMed ID: 25533623 [TBL] [Abstract][Full Text] [Related]
49. The importance of Toll-like receptor 4 during experimental Sporothrix brasiliensis infection. Rossato L; Santos SSD; Ferreira LG; de Almeida SR Med Mycol; 2019 Jun; 57(4):489-495. PubMed ID: 30085101 [TBL] [Abstract][Full Text] [Related]
50. Phenotypic characteristics associated with virulence of clinical isolates from the Sporothrix complex. Almeida-Paes R; de Oliveira LC; Oliveira MM; Gutierrez-Galhardo MC; Nosanchuk JD; Zancopé-Oliveira RM Biomed Res Int; 2015; 2015():212308. PubMed ID: 25961005 [TBL] [Abstract][Full Text] [Related]
51. Clotrimazole is highly effective in vitro against feline Sporothrix brasiliensis isolates. Gagini T; Borba-Santos LP; Messias Rodrigues A; Pires de Camargo Z; Rozental S J Med Microbiol; 2017 Nov; 66(11):1573-1580. PubMed ID: 28984226 [TBL] [Abstract][Full Text] [Related]
52. Molecular-based assessment of diversity and population structure of Sporothrix spp. clinical isolates from Espírito Santo-Brazil. da Cruz Bahiense Rocha I; Terra PPD; Cardoso de Oliveira R; Lubianca Zanotti R; Falqueto A; de Camargo ZP; Rodrigues AM; Gonçalves SS Mycoses; 2021 Apr; 64(4):420-427. PubMed ID: 33338280 [TBL] [Abstract][Full Text] [Related]
53. Miltefosine is active against Sporothrix brasiliensis isolates with in vitro low susceptibility to amphotericin B or itraconazole. Borba-Santos LP; Gagini T; Ishida K; de Souza W; Rozental S J Med Microbiol; 2015 Apr; 64(Pt 4):415-422. PubMed ID: 25681323 [TBL] [Abstract][Full Text] [Related]
54. Proteins Potentially Involved in Immune Evasion Strategies in Rossato L; Moreno LF; Jamalian A; Stielow B; de Almeida SR; de Hoog S; Freeke J mSphere; 2018 Jun; 3(3):. PubMed ID: 29898987 [No Abstract] [Full Text] [Related]
55. Natural killer cells are pivotal for in vivo protection following systemic infection by Sporothrix schenckii. Ferreira LS; Portuondo DL; Polesi MC; Carlos IZ Immunology; 2018 Dec; 155(4):467-476. PubMed ID: 30030839 [TBL] [Abstract][Full Text] [Related]
56. Molecular epidemiology of human sporotrichosis in Venezuela reveals high frequency of Sporothrix globosa. Camacho E; León-Navarro I; Rodríguez-Brito S; Mendoza M; Niño-Vega GA BMC Infect Dis; 2015 Feb; 15():94. PubMed ID: 25880588 [TBL] [Abstract][Full Text] [Related]
57. Role of TLR-2 and fungal surface antigens on innate immune response against Sporothrix schenckii. Negrini Tde C; Ferreira LS; Alegranci P; Arthur RA; Sundfeld PP; Maia DC; Spolidorio LC; Carlos IZ Immunol Invest; 2013; 42(1):36-48. PubMed ID: 23231043 [TBL] [Abstract][Full Text] [Related]
58. Mast cell activation by conidia of Sporothrix schenckii: role in the severity of infection. Romo-Lozano Y; Hernández-Hernández F; Salinas E Scand J Immunol; 2012 Jul; 76(1):11-20. PubMed ID: 22486186 [TBL] [Abstract][Full Text] [Related]